Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis

Ano

2018

Tipo de Documento

Artigos

Departamentos

Departamento de Sócio Farmácia

iMed.ULisboa

Referência

Fachi MM, Tonin FS, Leonart LP, Aguiar KS, Lenzi L, Figueiredo BC, Fernandez-Llimos F, Pontarolo R.. Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis. European Journal Of Cancer. 2018. 104. 9-20